New breast cancer trial aims to wipe out tumors before surgery
NCT ID NCT06535893
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding new drugs to standard chemotherapy before surgery can eliminate early-stage breast cancer (stage II-III) more effectively. About 100 participants will receive either standard treatment or an experimental combination. The main goal is to see if the cancer completely disappears in the breast and lymph nodes at the time of surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nagoya City University
RECRUITINGNagoya, Aichi-ken, 467-8601, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?